Operating Lease, Right-of-Use Asset of LeonaBio, Inc. from 30 Sep 2020 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
LeonaBio, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 30 Sep 2020 to 30 Sep 2025.
  • LeonaBio, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $607,000, a 30% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

LeonaBio, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $607,000 -$264,000 -30% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $676,000 -$257,000 -28% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $743,000 -$249,000 -25% 31 Mar 2025 10-Q 09 May 2025 2025 Q1
Q4 2024 $808,000 -$241,000 -23% 31 Dec 2024 10-Q 06 Nov 2025 2025 Q3
Q3 2024 $871,000 -$234,000 -21% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $933,000 -$226,000 -20% 30 Jun 2024 10-Q 01 Aug 2024 2024 Q2
Q1 2024 $992,000 -$220,000 -18% 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 $1,049,000 -$214,000 -17% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 $1,105,000 -$481,000 -30% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $1,159,000 -$489,000 -30% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 $1,212,000 -$203,000 -14% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $1,263,000 -$197,000 -13% 31 Dec 2022 10-K 22 Feb 2024 2023 FY
Q3 2022 $1,586,000 +$82,000 +5.5% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 $1,648,000 +$101,000 +6.5% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 $1,415,000 -$11,000 -0.77% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 $1,460,000 +$524,000 +56% 31 Dec 2021 10-K 23 Mar 2023 2022 FY
Q3 2021 $1,504,000 +$545,000 +57% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 $1,547,000 30 Jun 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 $1,426,000 31 Mar 2021 10-Q 13 May 2021 2021 Q1
Q4 2020 $936,000 31 Dec 2020 10-K 28 Mar 2022 2021 FY
Q3 2020 $959,000 30 Sep 2020 10-Q 12 Nov 2020 2020 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.